Page 93 - Sohini Das

Covid-19: Testing times for plasma banks as demand goes through the roof

The first of a two-part series looks at challenges involved in plasma therapy

Covid-19 crisis: Briton Pharma gets DCGI nod to launch favipiravir

Pune-based Brinton Pharmaceuticals said on Thursday it had got the nod from the Drugs Controller General of India (DCGI) to market its brand Faviton, priced at Rs 59 per tablet

Cheaper favipiravir brand gets nod, to enter market at Rs 59 a pill

The product comes Pune-based Brinton Pharma; Glenmark's FabiFlu is priced at Rs 73 a tablet

MyLab Discovery Solutions' Covid-19 antigen testing kits get ICMR nod

MyLab's kit named 'Pathocatch' will be available for orders immediately and will be priced at around Rs 450

Covid-19 crisis: Glenmark claims 'clinical cure in 4 days' in Phase-3 trial

Firm claims trial results showed 28.6% faster viral clearance in overall population, says drug well tolerated with no major side effects

Govt notifies incentive scheme for local API manufacturing to cut imports

According to a government notification, bulk drugs accounted for 63 per cent of total pharmaceutical imports in the country in 2018-19.

We want to price Covid-19 vaccine below Rs 1,000: Serum Institute CEO

Pune's Serum Institute of India is placing its bets on the Oxford-AstraZeneca vaccine candidate AZD1222

FabiFlu cheaper than other drugs to treat Covid-19, claims Glenmark

The company further claimed that since favipiravir was an oral therapy, patients could be treated on an out-patient basis without incurring additional hospitalisation expenses

Covid-19 treatment: A lowdown on possible cure and drugs being used

Business Standard takes a look at the common drugs that are being used in India for treating Covid-19 patients

Glenmark under fire for over pricing, 'misguided' claims of Covid-19 drug

NCP legislator Amol Kolhe's letter to Health Minister Harsh Vardhan triggers the DCGI to seek details from the Mumbai-based drugmaker

Covid-19: Vaccine firms give Moderna a shrug, say no rush on tie-ups

Most players that Business Standard spoke to said they would be concentrating on their own vaccine candidates or the current tie-ups that they have

India to launch Covid-19 vaccine by August 15: ICMR chief Bhargava

ICMR and Hyderabad-based Bharat Biotech are jointly working on preclinical as well as clinical development of Covaxin

Covid-19 crisis: Race to develop vaccine gets a booster as field widens

On Thursday, CDSCO also approved Zydus Cadila's plasmid DNA vaccine candidate ZyCoV-D, developed at its Vaccine Technology Centre in Ahmedabad.

GI Council wants standard Covid treatment rates for easier claim settlement

Insurers will be guided by referral rates while processing hospitalisation claims. If actual charges exceed referral rates due to various medical exigencies, insurers will consider them while processi

KKR to acquire controlling stake in JB Chemicals for Rs 3,750 crore

The total deal size thus will be around $500 mn or around Rs 3,750 crore

More drugs may see price revisions as raw material costs, expenses rise

API prices have gone up by 25-30 per cent for some drugs in recent months

As cases rise, surge in bio-waste raises a fresh challenge in Covid fight

Used protective gear, masks, gloves and syringes add to environmental concerns as well as financial costs of hospitals

Policy flip-flops may puncture India's image as 'pharmacy of the world'

India supplies almost 20 per cent of the medicines consumed by the world. Every third tablet in the US market is from India

DRL to launch innovator brand of favipiravir, is silent on pricing

Ties up with Fujifilm for exclusive rights over Avigan for Indian market, can sell overseas too

China crisis, India scouting for APIs a shot in arm for sick pharma PSU

Govt is trying to reduce dependence on China for APIs and develop indigenous sources